Rebleeding after minimally invasive surgery for intracerebral hemorrhage: A mini-review

被引：1

作者：

Guo, Wenliang ^{[1
]}

Guo, Guangyu ^{[1
]}

Bai, Shuang ^{[1
]}

Deng, Hong ^{[1
]}

Tang, Yuping ^{[2
]}

Yang, Qingwu ^{[3
]}

Dong, Qiang ^{[2
]}

Wang, Wenzhi ^{[4
]}

Pan, Chao ^{[1
]}

Tang, Zhouping ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, 1095 Jiefang Ave, Wuhan 430030, Peoples R China

[2] Fudan Univ, Huashan Hosp, Dept Neurol, State Key Lab Med Neurobiol, Shanghai, Peoples R China

[3] Army Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China

[4] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China

来源：

BRAIN HEMORRHAGES | 2021年 / 2卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Intracerebral hemorrhage; Minimally invasive surgery; Rebleeding; TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; MATRIX-METALLOPROTEINASE; STEREOTACTIC ASPIRATION; MEDIATED DISRUPTION; CEREBRAL-ISCHEMIA; HEMATOMA VOLUME; DELAYED EDEMA; EVACUATION; THERAPY;

D O I：

10.1016/j.hest.2020.09.002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Intracerebral hemorrhage (ICH) is the most disabling form of stroke, but effective treatment protocols for ICH are still limited. The minimally invasive surgery (MIS) is a potential and effective treatment for ICH in recent years. However, it is associated with a risk of rebleeding. This review aims to discuss some key facts about rebleeding, such as thrombolytic agents, therapeutic time window, and first aspiration volume.(c) 2020 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：24 / 28

页数：5

共 50 条

[1] Advances in the management of intracerebral hemorrhage [J].

Adeoye, Opeolu ;

Broderick, Joseph P. .

NATURE REVIEWS NEUROLOGY, 2010, 6 (11) :593-601

[2] VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown [J].

Argaw, Azeb Tadesse ;

Gurfein, Blake T. ;

Zhang, Yueting ;

Zameer, Andleeb ;

John, Gareth R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (06) :1977-1982

[3] New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies [J].

Aronowski, J ;

Hall, CE .

NEUROLOGICAL RESEARCH, 2005, 27 (03) :268-279

[4] Modern Approaches to Evacuating Intracerebral Hemorrhage [J].

Bhatia, Kunal ;

Hepburn, Madihah ;

Ziu, Endrit ;

Siddiq, Farhan ;

Qureshi, Adnan I. .

CURRENT CARDIOLOGY REPORTS, 2018, 20 (12)

[5] CTA Spot Sign Predicts Hematoma Expansion in Patients with Delayed Presentation After Intracerebral Hemorrhage [J].

Brouwers, H. Bart ;

Falcone, Guido J. ;

McNamara, Kristen A. ;

Ayres, Alison M. ;

Oleinik, Alexandra ;

Schwab, Kristin ;

Romero, Javier M. ;

Viswanathan, Anand ;

Greenberg, Steven M. ;

Rosand, Jonathan ;

Goldstein, Joshua N. .

NEUROCRITICAL CARE, 2012, 17 (03) :421-428

[6] Endoscopic surgery for spontaneous basal ganglia hemorrhage: comparing endoscopic surgery, stereotactic aspiration, and craniotomy in noncomatose patients [J].

Cho, Der-Yang ;

Chen, Chun-Chung ;

Chang, Cheng-Siu ;

Lee, Wen-Yuan ;

Tso, Melain .

SURGICAL NEUROLOGY, 2006, 65 (06) :547-556

[7] Defining hematoma expansion in intracerebral hemorrhage Relationship with patient outcomes [J].

Dowlatshahi, D. ;

Demchuk, A. M. ;

Flaherty, M. L. ;

Ali, M. ;

Lyden, P. L. ;

Smith, E. E. .

NEUROLOGY, 2011, 76 (14) :1238-1244

[8]

Ebina K, 1976, P 5 C SURG TREATM ST, P19

[9] The rtPA increases MMP-9 activity in serum during ischaemic stroke [J].

Golab, Piotr ;

Boguszewska-Czubara, Anna ;

Kielbus, Michal ;

Kurzepa, Jacek .

NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2014, 48 (05) :309-314

[10] Intracerebral hemorrhage-induced neuronal death [J].

Gong, C ;

Boulis, N ;

Qian, J ;

Turner, DE ;

Hoff, JT ;

Keep, RF .

NEUROSURGERY, 2001, 48 (04) :875-882

← 1 2 3 4 5 →